Paul R. Walker

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash et al. · JAMA Oncology · 2020 · 489 citations · Full text

Medicine, Immunology, Oncology +17

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman Stroud, Aparna Hegde, Cynthia R. Cherry et al. · Journal of Oncology Pharmacy Practice · 2017 · 328 citations

Pharmacy, Immunology, Pharmacotherapy +17

Homing Phenotypes of Tumor-Specific CD8 T Cells Are Predetermined at the Tumor Site by Crosspresenting APCs

Thomas Calzascia, Frédérick Masson, Wilma Di Berardino-Besson et al. · Immunity · 2005 · 233 citations · Full text

Life Sciences, Cancer Biology, Immunology +14

Brain Microenvironment Promotes the Final Functional Maturation of Tumor-Specific Effector CD8+ T Cells

Frédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson et al. · The Journal of Immunology · 2007 · 112 citations · Full text

Medicine, Immunology, Oncology +17

The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer

Tithi Biswas, Jimmy T. Efird, Shreya Prasad et al. · Oncotarget · 2017 · 109 citations · Full text

Medicine, Oncology, Breast Oncology +16